Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 1
1993 2
1995 1
1996 2
1997 3
1998 4
1999 3
2000 2
2001 2
2002 1
2003 2
2004 2
2005 2
2006 2
2007 1
2008 3
2009 4
2010 1
2011 4
2012 2
2013 3
2014 1
2015 7
2016 5
2017 2
2018 9
2019 11
2020 6
2021 5
2022 6
2023 5
2024 5
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, Khwaja A, Friis L, McMullin MF, Hunter A, Clark RE, Grimwade D; UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group. Burnett AK, et al. Among authors: friis l. Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14. Lancet Oncol. 2015. PMID: 26384238 Clinical Trial.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Free PMC article. Clinical Trial.
The Danish National Acute Leukemia Registry.
Østgård LS, Nørgaard JM, Raaschou-Jensen KK, Pedersen RS, Rønnov-Jessen D, Pedersen PT, Dufva IH, Marcher CW, Nielsen OJ, Severinsen MT, Friis LS. Østgård LS, et al. Among authors: friis ls. Clin Epidemiol. 2016 Oct 25;8:553-560. doi: 10.2147/CLEP.S99460. eCollection 2016. Clin Epidemiol. 2016. PMID: 27822099 Free PMC article. Review.
Outpatient Management of Patients Conditioned with Fludarabine and Treosulfan prior to Allogeneic Hematopoietic Cell Transplantation.
Schovsbo JS, Kjeldsen L, Nørskov KH, Sengeløv H, Kornblit BT, Schjødt I, Petersen SL, Nygaard M, Andersen NS, Mortensen BK, Friis LS. Schovsbo JS, et al. Among authors: friis ls. Transplant Cell Ther. 2025 Jan;31(1):28.e1-28.e10. doi: 10.1016/j.jtct.2024.11.001. Epub 2024 Nov 9. Transplant Cell Ther. 2025. PMID: 39522721 Free article.
Functional immune reconstitution after allogeneic hematopoietic stem cell transplantation in myeloablative and non-myeloablative conditioned patients.
Brooks PT, Minculescu L, Svanberg Teglgaard R, Hartling HJ, Salado-Jimena JA, Friis LS, Kornblit B, Schjødt I, Petersen SL, Andersen NS, Nielsen SD, Lundgren J, Marquart HV, Gjaerde LK, Sengeløv H, Ostrowski SR. Brooks PT, et al. Among authors: friis ls. Sci Rep. 2025 Jul 1;15(1):21029. doi: 10.1038/s41598-025-06718-y. Sci Rep. 2025. PMID: 40595122 Free PMC article.
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT.
Battipaglia G, Polverelli N, Tuffnell J, Chiusolo P, Robin M, Gambella M, Broers A, Sala E, Passweg J, Furst S, Friis LS, Dulery R, de Witte M, Srour M, Finazzi MC, Wehr C, Nagler A, Richardson D, Bethge W, Clark A, Drozd-Sokolowska J, Raj K, Czerw T, Hernández-Boluda JC, McLornan DP. Battipaglia G, et al. Among authors: friis ls. Curr Res Transl Med. 2025 Jan-Mar;73(1):103476. doi: 10.1016/j.retram.2024.103476. Epub 2024 Oct 29. Curr Res Transl Med. 2025. PMID: 39461096 Free article.
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT.
Henoun Loukili N, Gras L, Koster L, Blaise D, Gedde-Dahl T, Maertens J, Friis LS, Mielke S, Chevallier P, Passweg JR, Byrne JL, Salmenniemi U, Ceballos P, Cornillon J, Sica S, Onida F, Scheid C, Gurnari C, Drozd-Sokolowska J, Raj K, Robin M, McLornan DP, Yakoub-Agha I. Henoun Loukili N, et al. Among authors: friis ls. Bone Marrow Transplant. 2025 Aug 29. doi: 10.1038/s41409-025-02682-3. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40883614
99 results